Aerovate Therapeutics, Inc. (AVTE) Depreciation USD 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Aerovate Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2021 to 2024.
  • Aerovate Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $28 K, a 33.3% increase year-over-year.
  • Aerovate Therapeutics, Inc. annual Depreciation for 2023 was $96 K, a 41.2% increase from 2022.
  • Aerovate Therapeutics, Inc. annual Depreciation for 2022 was $68 K, a 353% increase from 2021.
  • Aerovate Therapeutics, Inc. annual Depreciation for 2021 was $15 K, a 1400% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $28 K +$7 K +33.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q1 2023 $21 K +$10 K +90.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $11 K +$9 K +450% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $2 K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.